rhinitis medicamentosa
Jump to navigation
Jump to search
Etiology
- rhinitis secondary to chronic use of decongestants or improper or excessive application of nasal preparation(s)
Epidemiology
- may be less common that than previously thought[1]
Pathology
- tolerance to decongestants (i.e. nasal vascoconstrictors such as oxymetazoline) leads to diminished effect with continued use, but worsening of nasal congestion with stopping its use
Management
- stop offending agent
- nasal glucocorticoids or nasal saline rinses may mitigate symptoms of decongestant withdrawal
More general terms
References
- ↑ 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 16, 18 American College of Physicians, Philadelphia 2012, 2018
- ↑ Doshi J. Rhinitis medicamentosa: what an otolaryngologist needs to know. Eur Arch Otorhinolaryngol. 2009 May;266(5):623-5 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19096862
- ↑ NEJM Knowledge+ Otolaryngology
Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148-55. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16784007 Free article. Review.
Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. J Otolaryngol Head Neck Surg. 2019 Dec 9;48(1):70. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31818321 PMCID: PMC6902618 Free PMC article.